mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
9e-18 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
4e-16 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-16 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
6e-16 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-15 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
4e-14 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-13 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-13 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-13 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-12 |